Rocket Pharmaceuticals
RCKT
RCKT
178 hedge funds and large institutions have $1.96B invested in Rocket Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 74 increasing their positions, 50 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
21% less capital invested
Capital invested by funds: $2.48B → $1.96B (-$522M)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
Holders
178
Holding in Top 10
4
Calls
$5.17M
Puts
$3.15M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$10.9M | |
| 3 | +$9.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.5M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$7.4M |
Top Sellers
| 1 | -$34M | |
| 2 | -$30.4M | |
| 3 | -$20.5M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$11.9M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.08M |